In vivo glucose monitoring: towards 'Sense and Act' feedback-loop individualized medical systems.

Glucose biosensors are key components of closed-loop glycaemic control (insulin delivery) systems for effective management of diabetes. By providing a fast return of the analytical information in a timely fashion, such sensors offer direct and reliable assessment of rapid changes in the glucose level, as desired for making optimal and timely therapeutic interventions in cases of hypo- and hyperglycemia. The majority of sensors used for continuous glucose monitoring are amperometric enzyme electrodes. The successful realization of closed-loop glycaemic control requires innovative approaches for addressing major challenges of biofouling, inflammatory response, calibration, stability, selectivity, power, miniaturization, common to other remote sensor systems. The goal of this review article is to demonstrate how these challenges are being addressed towards achieving reliable continuous subcutaneous monitoring of glucose. While the concept is presented here in connection to the management of diabetes, such loop-based individualized integrated (sensing/release) medical systems should lead to a fine-tune drug therapy and should have an enormous impact upon the treatment and management of different diseases.

[1]  D. J. Harrison,et al.  Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. , 1993, Analytical chemistry.

[2]  J. A. Hubbell,et al.  Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrode. , 1994, Analytical chemistry.

[3]  J. Wang,et al.  One-step electropolymeric co-immobilization of glucose oxidase and heparin for amperometric biosensing of glucose. , 2000, The Analyst.

[4]  D. Gough,et al.  Two-dimensional enzyme electrode sensor for glucose. , 1985, Analytical chemistry.

[5]  G. S. Wilson,et al.  Design and in vitro studies of a needle-type glucose sensor for subcutaneous monitoring. , 1991, Analytical chemistry.

[6]  Adam Heller,et al.  Integrated medical feedback systems for drug delivery , 2005 .

[7]  Russell O. Potts,et al.  Electroanalysis of Glucose in Transcutaneously Extracted Samples , 2000 .

[8]  Adam Heller,et al.  Ionic conduction in Zn3(PO4)2.4H2O enables efficient discharge of the zinc anode in serum. , 2005, Journal of the American Chemical Society.

[9]  G. S. Wilson,et al.  In vitro and in vivo evaluation of oxygen effects on a glucose oxidase based implantable glucose sensor , 1993 .

[10]  C. Malitesta,et al.  Glucose fast-response amperometric sensor based on glucose oxidase immobilized in an electropolymerized poly(o-phenylenediamine) film. , 1990, Analytical chemistry.

[11]  Adam Heller,et al.  Potentially implantable miniature batteries , 2006, Analytical and bioanalytical chemistry.

[12]  A Heller,et al.  A miniature biofuel cell. , 2001, Journal of the American Chemical Society.

[13]  George M. Whitesides,et al.  Polymeric Thin Films That Resist the Adsorption of Proteins and the Adhesion of Bacteria , 2001 .

[14]  Mark E Meyerhoff,et al.  In vivo chemical sensors: tackling biocompatibility. , 2006, Analytical chemistry.